AU StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Anagenics Ltd

0.006

0.000

Volume:93.88K

Turnover:563.00

Market Cap:2.98M

PE:-0.35

High:0.006

Open:0.006

Low:0.006

Close:0.006

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Anagenics Ltd

Exchange:

ASX

Establishment Date:

2004

Employees:

- -

Office Location:

55 Clarence Street,Suite 204,Level 2,Sydney,New South Wales,Australia

Website:

http://www.cellmid.com.au

Zip Code:

2000

Phone:

Fax:

61 2 9221 8535

Introduction:

Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/AN1.AU/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"AN1.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AN1.AU\",,,,,undefined,":{"symbol":"AN1.AU","market":"AU","secType":"STK","nameCN":"Anagenics Ltd","latestPrice":0.006,"timestamp":1749190320000,"preClose":0.006,"halted":0,"volume":93877,"delay":0,"nameEN":"Anagenics Ltd","floatShares":165868973,"shares":496320360,"eps":-0.017142,"marketStatus":"Market Closed","change":0,"latestTime":"06-06 16:12:00 AEST","open":0.006,"high":0.006,"low":0.006,"amount":563,"amplitude":0,"askPrice":0.008,"askSize":1772046,"bidPrice":0.006,"bidSize":290364,"shortable":3,"etf":0,"ttmEps":-0.017142,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1749513600000},"marketStatusCode":7,"adr":0,"exchange":"ASX","adjPreClose":0.006,"openAndCloseTimeList":[[1749168000000,1749189600000]],"volumeRatio":0.24636864945278983,"lotSize":0},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"AN1.AU\",,,,,undefined,":{"symbol":"AN1.AU","floatShares":165868973,"roa":"-27.30%","roe":"-135.49%","lyrEps":-0.018781,"volumeRatio":0.24636864945278983,"shares":496320360,"dividePrice":0,"high":0.006,"amplitude":0,"preClose":0.006,"low":0.006,"week52Low":0.005,"pbRate":"1.32","psRate":"0.41","week52High":0.01,"institutionHeld":0,"latestPrice":0.006,"committee":-0.718423,"eps":-0.017142,"divideRate":0,"volume":93877,"delay":0,"ttmEps":-0.017142,"open":0.006,"prevYearClose":0.008,"prevWeekClose":0.006,"prevMonthClose":0.006,"prevQuarterClose":0.008,"fiveDayClose":0.006,"twentyDayClose":0.007,"sixtyDayClose":0.008},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":22744699,"yearFounded":2004,"address":"55 Clarence Street,Suite 204,Level 2,Sydney,New South Wales,Australia","zipCode":"2000","officePhone":"61 2 9221 6830","officeFax":"61 2 9221 8535"},"stockCompanyDetail":{"websiteUrl":"http://www.cellmid.com.au","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.1429},{"period":"3month","weight":-0.25},{"period":"6month","weight":-0.25},{"period":"1year","weight":-0.1429},{"period":"ytd","weight":-0.25}],"compareEarnings":[{"period":"1week","weight":0.0014},{"period":"1month","weight":0.0414},{"period":"3month","weight":0.0546},{"period":"6month","weight":0.1356},{"period":"1year","weight":0.1958},{"period":"ytd","weight":0.1466}],"compareStock":{"symbol":"F100.AU","name":"BETASHARES FTSE 100 ETF"},"description":"Cellmid Limited, a life sciences company, develops and commercializes diagnostic and therapeutic products for cancer and various chronic inflammatory conditions in Australia, the United States, and Japan. The company offers Midkine (MK) ELISA Kit, a cancer biomarker, and diagnostic and prognostic tool. It is also developing CAB102, a humanized monoclonal antibody for use in solid tumors; CAB101, a monoclonal antibody for the treatment of kidney injury, and inflammatory and fibrotic diseases; and CMK103, a recombinant human form of MK protein for use in cardiac ischemia. In addition, the company develops and sells over-the-counter products; and a range of FGF5 inhibitor hair growth products. Cellmid Limited was incorporated in 2004 and is based in Sydney, Australia.","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.005208},{"month":2,"riseRate":0.5,"avgChangeRate":0.034268},{"month":3,"riseRate":0,"avgChangeRate":-0.168242},{"month":4,"riseRate":0.25,"avgChangeRate":-0.176731},{"month":5,"riseRate":0.25,"avgChangeRate":-0.106818},{"month":6,"riseRate":0.666667,"avgChangeRate":0.108376},{"month":7,"riseRate":0.666667,"avgChangeRate":0.066138},{"month":8,"riseRate":0.666667,"avgChangeRate":0.101425},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014493},{"month":10,"riseRate":0,"avgChangeRate":-0.126587},{"month":11,"riseRate":0,"avgChangeRate":-0.045977},{"month":12,"riseRate":0,"avgChangeRate":-0.095307}],"exchange":"ASX","name":"Anagenics Ltd","nameEN":"Anagenics Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"AN1.AU\",market:\"AU\",,,undefined,":null,"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/AN1.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"AN1.AU\",market:\"AU\",,,undefined,":[]}}